Sign in

Private company

SHL TELEMEDICINE LTD

SHL TELEMEDICINE LTD is an offices and Clinics of Doctors of Medicine services company.1

Last updated Oct 21, 2026.

Overview

$56.8MRevenue, fiscal 20242
-$27.8MNet income, fiscal 20242
  • IndustryServices-Offices & Clinics of Doctors of Medicine1
  • HeadquartersL31
  • Incorporated inIsrael3
  • Business address90 Yigal Alon Street, Tel Aviv3
  • Filer categoryNon-accelerated filer, Emerging growth company3

See how the biggest companies compare on our leaderboards

No information contained on our website is intended to be included as part of, or incorporated by reference in, this Annual Report.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2024

45.4%Gross margin2
-47.2%Operating margin2
-48.9%Net margin2
-0.5%Revenue growth, 20242
-70.7%Return on equity2
0.21×Debt to equity2
-$1.3MFree cash flow2

Where the money goes

Where each dollar of revenue went, fiscal 2024

  • Cost of revenue55¢$31.0M
  • Research and development9¢$5.4M
  • Other costs32¢$18.4M
  • Interest2¢$1.1M
  • Income tax2¢$939.0K

Out of $56.8M in revenue.2 The company lost money this year.

Financial statements

Revenue562$56.8M in 2024+41% since 2020
0$20.0M$40.0M$60.0M2020: $40.2M$40.2M20202021: $49.6M$49.6M2021+23%2022: $59.0M$59.0M2022+19%2023: $57.1M$57.1M2023−3%2024: $56.8M$56.8M2024−1%
Gross profit562$25.8M in 2024+25% since 2020
0$10.0M$20.0M$30.0M2020: $20.6M$20.6M20202021: $24.6M$24.6M2021+19%2022: $27.2M$27.2M2022+11%2023: $25.3M$25.3M2023−7%2024: $25.8M$25.8M2024+2%
Operating income562-$26.8M in 2024
-$30.0M-$20.0M-$10.0M0$10.0M2020: $396.0K$396.0K20202021: -$497.0K-$497.0K20212022: -$5.2M-$5.2M2022+939%2023: -$9.0M-$9.0M2023+74%2024: -$26.8M-$26.8M2024+198%
Net income562-$27.8M in 2024
-$30.0M-$20.0M-$10.0M0$10.0M2020: $278.0K$278.0K20202021: -$13.9M-$13.9M20212022: $215.0K$215.0K20222023: -$6.9M-$6.9M20232024: -$27.8M-$27.8M2024+305%
Fiscal year2018201920202021202220232024
Revenue$40.2M5$49.6M6$59.0M2$57.1M2$56.8M2
Cost of revenue$25.0M6$31.8M2$31.8M2$31.0M2
Gross profit$20.6M5$24.6M6$27.2M2$25.3M2$25.8M2
Research and development$3.0M6$3.8M2$5.3M2$5.4M2
Operating income$396.0K5-$497.0K6-$5.2M2-$9.0M2-$26.8M2
Interest$529.0K6$1.0M2$1.3M2$1.1M2
Income before tax-$13.5M6$1.3M2-$6.0M2-$26.8M2
Income tax$455.0K6$1.1M2$891.0K2$939.0K2
Net income$278.0K5-$13.9M6$215.0K2-$6.9M2-$27.8M2
Earnings per share$0.035-$1.006-$0.012-$0.432-$1.712
Earnings per share (diluted)$0.035-$1.006-$0.492-$0.542-$1.712
Shares (weighted, basic)14.0M shares514.5M shares616.3M shares216.4M shares2
Shares (weighted, diluted)14.0M shares515.2M shares616.3M shares216.4M shares2

Compare SHL TELEMEDICINE LTD with another company

Corporate structure

SHL TELEMEDICINE LTD sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of SHL TELEMEDICINE LTD

  • SHL TELEMEDICINE LTD L3

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What SHL TELEMEDICINE LTD reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, net$5.0M2 Dec 31, 2024$4.9M2 Dec 31, 2023+1.4%
Operating-lease assets (leased space)$5.8M2 Dec 31, 2024$7.2M2 Dec 31, 2023−19.2%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$7.7M2 Dec 31, 2024$6.7M2 Dec 31, 2023+14.7%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$19.1M2 Dec 31, 2024$33.0M2 Dec 31, 2023−42.0%
Intangible assets, net (excluding goodwill)$15.7M2 Dec 31, 2024$20.3M2 Dec 31, 2023−22.5%

Inventory

ItemLatestA year beforeChange
Inventory, total$1.2M2 Dec 31, 2024$3.5M2 Dec 31, 2023−66.1%

Leadership

Who has led SHL TELEMEDICINE LTD, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. David Arnon2026–now

Chief financial officer

  1. Lior Haalman2026–now
Board members and other officers (6)

Timeline

  1. Mar 25, 2026New chief executive David Arnon becomes CEO7

Filings

98 filings to the SEC since October 2021: 5 annual reports, 8 insider forms, 9 large holders, 76 other. The latest 20:

  1. Mar 30, 20263 EDGAR
  2. Mar 25, 20263 EDGAR
  3. Mar 25, 20263 EDGAR
  4. Mar 25, 20263 EDGAR
  5. Mar 25, 20263 EDGAR
  6. Mar 25, 20263 EDGAR
  7. Mar 25, 20263 EDGAR
  8. Mar 25, 20263 EDGAR
  9. Feb 2, 202615F-12B EDGAR
  10. Dec 15, 2025SCHEDULE 13D/A EDGAR
  11. Dec 5, 2025SCHEDULE 13D/A EDGAR
  12. Dec 3, 20256-K EDGAR
  13. Nov 21, 20256-K EDGAR
  14. Nov 20, 20256-K EDGAR
  15. Oct 30, 20256-K EDGAR
  16. Sep 16, 20256-K EDGAR
  17. Sep 11, 20256-K EDGAR
  18. Aug 12, 20256-K EDGAR
  19. May 28, 20256-K EDGAR
  20. May 20, 20256-K EDGAR

The 98 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How SHL TELEMEDICINE LTD is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARSHL TELEMEDICINE LTD1
  • CIK0001166834
  • Filer statusNon-accelerated filer an emerging growth company; not a shell company4
  • Incorporated inIllinois4
  • Fiscal year endsDecember 311
  • Industry code (SIC)8011 Services-Offices & Clinics of Doctors of Medicine1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address90 Yigal Alon Street, Tel Aviv, Israel1
  • Phone972-3-56122121
  • Shares outstanding16,392,754 shares as of Dec 31, 20244
  • AuditorEY Global, Tel-Aviv, Israel PCAOB ID 1281; no auditor attestation of internal control over financial reporting4
  • On EDGAR sinceFeb 11, 20021
  • Filings103 in all: 6-K (44), 3 (8), UPLOAD (6), CORRESP (5), 20-F (3), 6-K/A (3), SC 13D (3), SC 13D/A (3)1
    All 28 form types

    SC 13G (3), 20-F/A (2), 20FR12B/A (2), EFFECT (2), NT 20-F (2), SCHEDULE 13D/A (2), SEC STAFF LETTER (2), 15F-12B (1), 20FR12B (1), 25 (1), CERT (1), DRS (1), DRS/A (1), DRSLTR (1), F-6 (1), POS AM (1), S-8 (1), S-8 POS (1), SC TO-C (1), SEC STAFF ACTION (1)

  • Latest filingsAnnual report (20-F) May 15, 2025

Securities registered for trading

ClassSymbolExchange
American Depositary Shares, each representing oneSHLT
Ordinary shares, nominal value NIS 0.01 per share

From the cover page of the 20-F filed May 15, 2025 (Section 12(b) of the Exchange Act).4

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18